The goal of universal health care requires an overhaul of the public health system, medical education and regulatory mechanisms. At long last, public health is on the agenda of the country’s policy makers. The Prime Minister’s Republic Day speech mentioned that the Twelfth Plan would focus on health just as the Eleventh Plan had focussed on education. But the manner in which the education sector has been messed with does not...

-The Telegraph The Centre today asked a panel of doctors to outline measures to improve drug approval procedures, three days after a parliamentary standing committee said India’s drug regulators had broken laws, ignoring the interests of patients. The panel announced by the Union health ministry has been asked to suggest steps to improve the procedural aspects of the Central Drugs Standards Control Organisation (CDSCO), the agency entrusted with approving medicines for sale...

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...

The recommendations of the Planning Commission’s High Level Expert Group on Access to Universal Healthcare are significant because they make explicit the need to contextualise health within the rights. However, the problem with the report is that it does not ask why many of the same recommendations that were made by previous committees have not been implemented. The HLEG neither recognises the problems, constraints and compulsions at the national, state...

-Daily Bhaskar   The malnourished children in tribal areas of Madhya Pradesh were subjected to drug trials by doctors at their clinics in defiance of set norms. Documents accessed by DNA reveal that 20 malnourished children who suffered tuberculosis were tested for Bonnisan – an ayurvedic drug manufactured by Indian pharmaceutical company – at Nainpur in Mandla district. All the patients were in infancy or early childhood. Their age ranged from 8 months...